Oliver T. Keppler
- Virology top 0.1%
- HIV Research and Treatment 66
- Immunology top 1%
- Immune Cell Function and Interaction 34
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research 21
- HIV/AIDS drug development and treatment 21
- HIV/AIDS Research and Interventions 15
- Epidemiology top 2%
- Cytomegalovirus and herpesvirus research 22
- Herpesvirus Infections and Treatments 11
- Molecular Biology top 5%
- Glycosylation and Glycoproteins Research 11
Oliver T. Keppler
130 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Virology 2.6k
- Immunology 2.0k
- Infectious Diseases 1.5k
- Epidemiology 1.3k
- Molecular Biology 2.3k
Countries citing papers authored by Oliver T. Keppler
This map shows the geographic impact of Oliver T. Keppler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver T. Keppler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver T. Keppler more than expected).
Fields of papers citing papers by Oliver T. Keppler
This network shows the impact of papers produced by Oliver T. Keppler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver T. Keppler. The network helps show where Oliver T. Keppler may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Oliver T. Keppler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 5 | |
| 7 | 2021 | 18 | |
| 8 | 2021 | 18 | |
| 9 | 2021 | 40 | |
| 10 | 2021 | 17 | |
| 11 | 2021 | 22 | |
| 12 | 2021 | 0 | |
| 13 | 2021 | 20 | |
| 14 | 2021 | 13 | |
| 15 | 2020 | 112 | |
| 16 | 2020 | 4 | |
| 17 | 2018 | 24 | |
| 18 | 2015 | 70 | |
| 19 | 2011 | 54 | |
| 20 | 2005 | 177 |
About Oliver T. Keppler
Oliver T. Keppler is a scholar working on Virology, Infectious Diseases and Immunology, having authored 135 papers that have together received 5.8k indexed citations. Recurring topics across this work include HIV Research and Treatment (66 papers), Immune Cell Function and Interaction (34 papers), Cytomegalovirus and herpesvirus research (22 papers), SARS-CoV-2 and COVID-19 Research (21 papers), HIV/AIDS drug development and treatment (21 papers), HIV/AIDS Research and Interventions (15 papers), Glycosylation and Glycoproteins Research (11 papers) and Herpesvirus Infections and Treatments (11 papers). The work is most often cited by research in Virology (2.6k citations), Immunology (2.0k citations) and Infectious Diseases (1.5k citations). Oliver T. Keppler has collaborated with scholars based in Germany, United States and France. Frequent co-authors include O. Fackler, Michael Pawlita, Werner Reutter, Ina Allespach, Christine Goffinet, Hans‐Georg Kräusslich, Stephan Hinderlich, Nico Michel, Sonja Welsch and Ina Ambiel. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.